insights_auto
Why is SCNI down 9.50%?
Dive Deeperchevron_right
SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$0.40
arrow_downward
-9.50%(-0.042) 1D
$0.44
arrow_upward
+10.45% (+0.042)bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$0.45
High
$0.45
Low
$0.39
Mkt. cap
1.06M
Avg. vol.
2.32M
Volume
94.99K
52-wk high
$13.00
52-wk low
$0.39
EPS
-$2.80
Beta
2.27
Shares outstanding
706.59K
No. of employees
45
Open
$0.45
High
$0.45
Low
$0.39
Mkt. cap
1.06M
Avg. vol.
2.32M
Volume
94.99K
52-wk high
$13.00
52-wk low
$0.39
EPS
-$2.80
Beta
2.27
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
ING Sprinters
·
2 days ago
De AEX Index blijft voortmodderen
Nieuws.nl
·
1 day ago
AEX-index lager door onrust rond Nvidia
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR
CEO-
Employees45
FoundedJan 1, 2003
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitescinai.com